CytomX Therapeutics Inc. (NASDAQ: CTMX)
$1.50
+0.0900 ( +6.38% ) 856.0K
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Market Data
Open
$1.50
Previous close
$1.41
Volume
856.0K
Market cap
$117.66M
Day range
$1.42 - $1.52
52 week range
$1.04 - $5.85
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 19, 2023 |
4 | Insider transactions | 1 | Dec 19, 2023 |
8-k | 8K-related | 13 | Nov 07, 2023 |
10-q | Quarterly Reports | 72 | Nov 07, 2023 |
4 | Insider transactions | 1 | Sep 22, 2023 |
4 | Insider transactions | 1 | Sep 22, 2023 |
4 | Insider transactions | 1 | Sep 22, 2023 |
4 | Insider transactions | 1 | Sep 22, 2023 |
8-k | 8K-related | 12 | Aug 24, 2023 |
8-k | 8K-related | 13 | Aug 08, 2023 |